

A Practical Guide to Predictable Immediate Implant Outcomes
Submit form to access the Ebook
Immediate implant placement in the esthetic zone requires more than technique, it demands the right biologic conditions, thoughtful planning, and disciplined execution.
This eBook delivers a practical five-step framework to help you evaluate cases, apply proven protocols, and manage hard and soft tissue with greater confidence. Designed to help improve predictability and long-term esthetic stability.

Discover the trusted foundation for reliable regeneration.
Geistlich Bio-Oss®, Geistlich Bio-Gide® and Geistlich Bio-Gide® Forte all define the gold standard in bone and tissue regeneration. Backed by more than 2,300 studies and trusted by over 21 million patients, they deliver results as healthy and stable as native bone – even after 20 years. 1,3-6
Their exceptional struture and consistent quality ensure predictable outcomes and long-lasting success. These are the most widely used and best-documented solutions in regenerative dentistry.

World-class education for real-world results.
We believe that sharing knowledge and expertise is essential for advancing clinical practice and achieving the best possible outcomes for patients. Every year, more than 3,000 Geistlich educational events around the world bring together over 100,000 participants.2
Through hands-on workshops, digital resources, and expert guidance, we empower dental professionals to master new techniques and achieve long-term success.
As the global leader in regenerative dentistry, Geistlich is committed to supporting your growth and helping you deliver excellence every step of the way.
- Jung RE, et al.: Clin Oral Implants Res 2021; 32(12): 1455–65. (clinical study)
- Data on file. Geistlich Pharma AG, Wolhusen, Switzerland. (Nr education events)
- iData Research, China market report suite for dental bone graft substitutes and other biomaterials, iDATA_CHDBGS18_MS, Nov 2018. (market research)
- iData Research, Europe market report suite for dental bone graft substitutes and other biomaterials, iDATA_EUDBGS19_MS, Jul 2019. (market research)
- iData Research, US market report suite for dental bone graft substitutes and other biomaterials, iDATA_USDBGS19_MS, Jan 2019. (market research)
- Data on file. Geistlich Pharma AG, Wolhusen, Switzerland. (Nr of patients treated with Geistlich Bio-Oss® & Nr of studies with Geistlich Bio-Oss® and Geistlich Bio-Gide®)

